Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 172,497 | 90,890 | 41,758 | 36,526 | 50,465 |
| Operating Income | -172,497 | -90,890 | -41,758 | -36,526 | -50,465 |
| Other Income | 6,824 | 10,286 | 4,809 | 1,171 | -171 |
| Pre-tax Income | -165,673 | -80,604 | -36,949 | -35,355 | -50,636 |
| Net Income Continuous | -165,673 | -80,604 | -36,949 | -35,355 | -50,636 |
| Net Income | $-165,673 | $-80,604 | $-36,949 | $-35,355 | $-50,636 |
| EPS Basic Total Ops | -2.27 | -1.32 | -0.84 | -1.37 | -2.95 |
| EPS Basic Continuous Ops | -2.27 | -1.32 | -0.84 | -1.37 | -2.95 |
| EPS Diluted Total Ops | -2.27 | -1.32 | -0.84 | -1.37 | -2.95 |
| EPS Diluted Continuous Ops | -2.27 | -1.32 | -0.84 | -1.37 | -2.95 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.32 | -0.84 | -1.37 | -2.95 |
| EBITDA(a) | $-173,845 | $-95,828 | $-43,290 | $-36,982 | $-50,153 |